Vivian P Bykerk (Vivian Bykerk)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 32

Top Topics

Rheumatoid Arthritis

Disease Activity

Systematic Review

Monoclonal Antibody

Top Venues

The Journal of rheumatology

Clinical rheumatology

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Roko P A Nikolic, Jordi Pardo Pardo, Janet E Pope, Claire E H Barber, Cheryl C M Barnabe, Orit Schieir, Shahin Jamal, Alexandra Legge, Bindee Kuriya, Pooneh Akhavan, J Carter Throne, Claire Bombardier, Regina M Taylor-Gjevre, Vivian P Bykerk, Majed Khraishi, Laurie Proulx, Dawn P Richards, Peter Tugwell, Arnav Agarwal, Nick Bansback, Glen Stewart Hazlewood
Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #2. The Journal of rheumatology (2024)
Roko P A Nikolic, Jordi Pardo Pardo, Janet E Pope, Claire E H Barber, Cheryl C M Barnabe, Orit Schieir, Shahin Jamal, Alexandra Legge, Bindee Kuriya, Pooneh Akhavan, J Carter Throne, Claire Bombardier, Regina M Taylor-Gjevre, Vivian P Bykerk, Majed Khraishi, Laurie Proulx, Dawn P Richards, Peter Tugwell, Arnav Agarwal, Nick Bansback, Glen Stewart Hazlewood
Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #2. The Journal of rheumatology 51 (9) (2024)
Nilasha Ghosh, Pankti Reid, Carlos Andres Aude, Jessica Kirschman, Susan M Goodman, Vivian P Bykerk, Amit Lakhanpal, Diviya Rajesh, Karmela K Chan, William H Robinson, Anne R Bass
Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 'shared epitope' are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than in longstanding rheumatoid arthritis. RMD open 9 (2) (2023)
Anthony Sebba, Clifton O Bingham, Vivian P Bykerk, Stefano Fiore, Kerri Ford, Jud C Janak, Dimitrios A Pappas, Taylor Blachley, Swapna S Dave, Joel M Kremer, Miao Yu, Ernest H S Choy
Comparative effectiveness of TNF inhibitor vs IL-6 receptor inhibitor as monotherapy or combination therapy with methotrexate in biologic-experienced patients with rheumatoid arthritis: An analysis from the CorEvitas RA Registry. Clinical rheumatology (2023)
Nilasha Ghosh, Pankti Reid, Carlos Andres Aude, Jessica Kirschman, Susan M Goodman, Vivian P Bykerk, Amit Lakhanpal, Diviya Rajesh, Karmela K Chan, William H Robinson, Anne R Bass
Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 'shared epitope' are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than in longstanding rheumatoid arthritis. RMD open 9 (2) (2023)
Chun Wu, Yanhua Hu, Peter Schafer, Sean E Connolly, Robert Wong, Signe Holm Nielsen, Anne-Christine Bay-Jensen, Paul Emery, Yoshiya Tanaka, Vivian P Bykerk, Clifton O Bingham, Thomas Wj Huizinga, Roy M Fleischmann, Jinqi Liu
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis. RMD open 8 (2) (2023)
Chun Wu, Yanhua Hu, Peter Schafer, Sean E Connolly, Robert Wong, Signe Holm Nielsen, Anne-Christine Bay-Jensen, Paul Emery, Yoshiya Tanaka, Vivian P Bykerk, Clifton O Bingham, Thomas Wj Huizinga, Roy M Fleischmann, Jinqi Liu
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis. RMD open 8 (2) (2023)
Charis F Meng, Diviya A Rajesh, Deanna P Jannat-Khat, Bridget Jivanelli, Vivian P Bykerk
The Gap in Knowledge about Tapering Targeted Therapy being used as Monotherapy in Rheumatoid Arthritis: A Systematic Review. Current rheumatology reviews (2023)
Glen Stewart Hazlewood, Pooneh Akhavan, Jordi Pardo Pardo, Arnav Agarwal, Orit Schieir, Claire E H Barber, Laurie Proulx, Dawn P Richards, Claire Bombardier, Janet E Pope, Cheryl C M Barnabe, Peter Tugwell, Shahin Jamal, J Carter Throne, Roko P A Nikolic, Majed Khraishi, Nick Bansback, Alexandra Legge, Vivian P Bykerk, Regina M Taylor-Gjevre
Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #1. The Journal of rheumatology (2023)
Gabriela L Maica, Christine Iannaccone, Vivi Feathers, Michelle L Frits, Vivian P Bykerk, Clifton O Bingham, Michael Weinblatt, Nancy A Shadick
Understanding Differences in Patient Descriptions of Rheumatoid Arthritis Flares Using OMERACT Core Domains. The Journal of rheumatology (2023)
Chun Wu, Yanhua Hu, Peter Schafer, Sean E Connolly, Robert Wong, Signe Holm Nielsen, Anne-Christine Bay-Jensen, Paul Emery, Yoshiya Tanaka, Vivian P Bykerk, Clifton O Bingham, Thomas Wj Huizinga, Roy M Fleischmann, Jinqi Liu
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis. RMD open 8 (2) (2023)
Chun Wu, Yanhua Hu, Peter Schafer, Sean E Connolly, Robert Wong, Signe Holm Nielsen, Anne-Christine Bay-Jensen, Paul Emery, Yoshiya Tanaka, Vivian P Bykerk, Clifton O Bingham, Thomas Wj Huizinga, Roy M Fleischmann, Jinqi Liu
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis. RMD open 8 (2) (2023)
Charis F Meng, Diviya A Rajesh, Deanna P Jannat-Khah, Bridget Jivanelli Gatto, Vivian P Bykerk
Can Patients With Controlled Rheumatoid Arthritis Taper Methotrexate From Targeted Therapy and Sustain Remission? A Systematic Review and Metaanalysis. The Journal of rheumatology (2022)
Susan J Bartlett, Vivian P Bykerk, Orit Schieir, Marie-France Valois, Janet E Pope, Gilles Boire, Carol A Hitchon, Glen Stewart Hazlewood, Louis Bessette, Edward C Keystone, Carter Thorne, Diane Tin, Clifton O Bingham, null null
"From Where I Stand": using multiple anchors yields different benchmarks for meaningful improvement and worsening in the rheumatoid arthritis flare questionnaire (RA-FQ). Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2022)
Medha Barbhaiya, Marianna B Frey, Jonah M Levine, Gregory J Vitone, Lindsay Lally, Michael D Lockshin, Vivian P Bykerk, Candace H Feldman, Lisa A Mandl
Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City. Clinical rheumatology 41 (8) (2022)
Glen Stewart Hazlewood, Jordi Pardo Pardo, Cheryl C M Barnabe, Orit Schieir, Claire E H Barber, Laurie Proulx, Dawn P Richards, Peter Tugwell, Nick Bansback, Pooneh Akhavan, Claire Bombardier, Vivian P Bykerk, Shahin Jamal, Majed Khraishi, Regina M Taylor-Gjevre, J Carter Throne, Arnav Agarwal, Janet E Pope
Canadian Rheumatology Association Living Guidelines for the Pharmacological Management of Rheumatoid Arthritis With Disease-Modifying Antirheumatic Drugs. The Journal of rheumatology 49 (10) (2022)
Glen Stewart Hazlewood, Orit Schieir, Vivian P Bykerk, Kamso Mujaab, Peter Tugwell, George Wells, Dawn Richards, Laurie Proulx, Pauline M Hull, Susan J Bartlett
Frequency of Symptomatic Adverse Events in Rheumatoid Arthritis: An Exploratory Online Survey. The Journal of rheumatology 49 (9) (2022)
Medha Barbhaiya, Jonah M Levine, Vivian P Bykerk, Deanna Jannat-Khah, Lisa A Mandl
Systemic rheumatic disease flares after SARS-CoV-2 vaccination among rheumatology outpatients in New York City. Annals of the rheumatic diseases 80 (10) (2021)
William Rigby, Jane H Buckner, S Louis Bridges, Marleen Nys, Sheng Gao, Martin Polinsky, Neelanjana Ray, Vivian P Bykerk
HLA-DRB1 risk alleles for RA are associated with differential clinical responsiveness to abatacept and adalimumab: data from a head-to-head, randomized, single-blind study in autoantibody-positive early RA. Arthritis research & therapy 23 (1) (2021)
Medha Barbhaiya, Jonah M Levine, Caroline H Siegel, Vivian P Bykerk, Deanna P Jannat-Khah, Lisa A Mandl
Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus. Clinical rheumatology (2021)
Glen Stewart Hazlewood, Claire Bombardier, Xiuying Li, Mohammad Movahedi, Denis Choquette, Louis Coupal, Vivian P Bykerk, Orit Schieir, Dianne Mosher, Deborah A Marshall, Sasha Bernatsky, Nicole Spencer, Dawn P Richards, Laurie Proulx, Claire E H Barber, null null
Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts. The Journal of rheumatology (2021)
Kathleen Michelle Andersen, Orit Schieir, Marie-France Valois, Susan J Bartlett, Louis Bessette, Gilles Boire, Boulos Haraoui, Glen Stewart Hazlewood, Carol A Hitchon, Edward C Keystone, Janet E Pope, Carter Thorne, J Carter Throne, Vivian P Bykerk, null null
A Bridge Too Far? Real-World Practice Patterns of Early Glucocorticoid Use in the Canadian Early Arthritis Cohort. ACR open rheumatology (2021)
Jeffrey R Curtis, Paul Emery, Elaine Karis, Boulos Haraoui, Vivian P Bykerk, Priscilla K Yen, Greg Kricorian, James B Chung
Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission. Arthritis & rheumatology (Hoboken, N.J.) 73 (5) (2021)
Cristiano Soares de Moura, Orit Schieir, Marie-France Valois, J Carter Throne, Susan J Bartlett, Janet E Pope, Carol A Hitchon, Gilles Boire, Boulos Haraoui, Glen Stewart Hazlewood, Edward C Keystone, Diane Tin, Vivian P Bykerk, Sasha Bernatsky, null null
Treatment Strategies in Early Rheumatoid Arthritis Methotrexate Management: Results From a Prospective Cohort. Arthritis care & research 72 (8) (2020)
Glen Stewart Hazlewood, Deborah A Marshall, Claire E H Barber, Linda C Li, Cheryl C M Barnabe, Vivian P Bykerk, Peter Tugwell, Pauline M Hull, Nick Bansback
Using a Discrete-Choice Experiment in a Decision Aid to Nudge Patients Towards Value-Concordant Treatment Choices in Rheumatoid Arthritis: A Proof-of-Concept Study. Patient preference and adherence 14 (2020)
David Kuo, Jennifer Ding, Ian S Cohn, Fan Zhang, Kevin Wei, Deepak A Rao, Cristina Rozo, Upneet K Sokhi, Sara Shanaj, David J Oliver, Adriana P Echeverria, Edward F DiCarlo, Michael B Brenner, Vivian P Bykerk, Susan M Goodman, Soumya Raychaudhuri, Gunnar Rätsch, Lionel B Ivashkiv, Laura T Donlin
HBEGF+ macrophages in rheumatoid arthritis induce fibroblast invasiveness. Science translational medicine 11 (491) (2020)
Kathleen Michelle Andersen, Ayano Kelly, Anne Lyddiatt, Clifton O Bingham, Vivian P Bykerk, Adena Batterman, Joan Westreich, Michelle K Jones, Marita Cross, Peter R Brooks, Lyn M March, Beverley J Shea, Peter Tugwell, Lee S Simon, Robin Christensen, Susan J Bartlett
Patient Perspectives on DMARD Safety Concerns in Rheumatology Trials: Results from Inflammatory Arthritis Patient Focus Groups and OMERACT Attendees Discussion. The Journal of rheumatology 46 (9) (2019)
Tim Pickles, Rieke E Alten, Maarten Boers, Vivian P Bykerk, Jared Christensen, Robin Christensen, Hubert van Hoogstraten, Lee S Simon, Lai Shan Tam, Ernest H S Choy
Adaptive Trial Designs in Rheumatology: Report from the OMERACT Special Interest Group. The Journal of rheumatology 46 (10) (2019)
Chamith Y Fonseka, Deepak A Rao, Nikola C Teslovich, Ilya Korsunsky, Susan K Hannes, Kamil Slowikowski, Michael F Gurish, Laura T Donlin, James A Lederer, Michael E Weinblatt, Elena M Massarotti, Jonathan S Coblyn, Simon M Helfgott, Derrick J Todd, Vivian P Bykerk, Elizabeth W Karlson, Joerg Ermann, Yvonne C Lee, Michael B Brenner, Soumya Raychaudhuri
Mixed-effects association of single cells identifies an expanded effector CD4+ T cell subset in rheumatoid arthritis. Science translational medicine 10 (463) (2019)
Taysir G Mahmoud, Jie Huang, Michelle Frits, Christine Iannaccone, Vivian P Bykerk, Clifton O Bingham, Michael Weinblatt, Nancy A Shadick
Correlates of Successful Rheumatoid Arthritis Flare Management: Clinician-driven Treatment, Home-based Strategies, and Medication Change. The Journal of rheumatology 47 (3) (2019)
Vivian P Bykerk
Low-dose Glucocorticoid Use Does Not Reduce Biologic Use in Early RA, Nor Do Biologics Reduce the Need for Glucocorticoids. The Journal of rheumatology 46 (4) (2019)
Vivian P Bykerk, Gerd R Burmester, Bernard G Combe, Daniel E Furst, Tom W J Huizinga, Harris A Ahmad, Paul Emery
On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis. Rheumatology international 38 (12) (2018)